NasdaqCM - Delayed Quote USD

Precision Optics Corporation, Inc. (POCI)

Compare
3.8500 0.0000 (0.00%)
At close: October 29 at 4:00 PM EDT
Loading Chart for POCI
DELL
  • Previous Close 3.8500
  • Open 3.9100
  • Bid --
  • Ask --
  • Day's Range 3.8500 - 4.0401
  • 52 Week Range 3.8000 - 6.9000
  • Volume 15,527
  • Avg. Volume 15,103
  • Market Cap (intraday) 24.448M
  • Beta (5Y Monthly) 0.17
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4900
  • Earnings Date Nov 12, 2024 - Nov 18, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies for industrial and military use. It markets its products to medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.

www.poci.com

83

Full Time Employees

June 30

Fiscal Year Ends

Recent News: POCI

View More

Performance Overview: POCI

Trailing total returns as of 10/29/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

POCI
36.05%
S&P 500
22.29%

1-Year Return

POCI
31.49%
S&P 500
41.67%

3-Year Return

POCI
43.47%
S&P 500
26.90%

5-Year Return

POCI
11.49%
S&P 500
91.91%

Compare To: POCI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: POCI

View More

Valuation Measures

Annual
As of 10/29/2024
  • Market Cap

    24.45M

  • Enterprise Value

    27.48M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.22

  • Price/Book (mrq)

    2.43

  • Enterprise Value/Revenue

    1.44

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.45%

  • Return on Assets (ttm)

    -9.29%

  • Return on Equity (ttm)

    -26.69%

  • Revenue (ttm)

    19.1M

  • Net Income Avi to Common (ttm)

    -2.95M

  • Diluted EPS (ttm)

    -0.4900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    405.28k

  • Total Debt/Equity (mrq)

    34.11%

  • Levered Free Cash Flow (ttm)

    -1.87M

Research Analysis: POCI

View More

Revenue vs. Earnings

Revenue 4.72M
Earnings -1.41M
 

Analyst Price Targets

 

Company Insights: POCI

People Also Watch